|
Investor Contact:
John Kristoff
John.Kristoff@Adtalem.com
312-651-1437
Media Contact:
Ernie Gibble
Ernie.Gibble@Adtalem.com
630-353-9920
|
|
•
|
Revenue of $254.6 million increased 7.5% compared with the prior year
|
|
•
|
Operating income from continuing operations was $25.7 million compared with a loss of $3.2 million in the prior year; operating income from
continuing operations, excluding special items, was $27.5 million compared with $36.2 million in the prior year
|
|
•
|
Net income was $14.4 million compared with a loss of $9.5 million in the prior year; net income from continuing operations, excluding special
items, was $18.9 million compared with $26.7 million in the prior year
|
|
•
|
Diluted earnings per share was $0.26 compared with a loss of $0.16 in the prior year; diluted earnings per share from continuing operations,
excluding special items, was $0.34 compared with $0.44 in the prior year. Approximately 0.9 million shares of common stock were repurchased during the first quarter of fiscal 2020 at an average purchase price of $43.81 for a total of
$40.3 million
|
|
•
|
Revenue is expected to grow 5% to 7% compared with the prior year
|
|
•
|
Effective income tax rate is expected to be in the 19% to 20% range
|
|
•
|
Earnings per share from continuing operations, excluding special items, are expected to grow in the 7 to 9% range compared with the prior year
|
|
•
|
Full-year capital spending is expected to be in the $45 million to $50 million range
|
|
1Q 2020
|
1Q 2019
|
% Change
|
|
|
Adtalem Global Education Student Enrollments(1)
|
|||
|
New students
|
6,467
|
6,324
|
+2.3%
|
|
Total students
|
37,344
|
37,182
|
+0.4%
|
|
Chamberlain University
|
|||
|
September Session
|
|||
|
New students
|
5,595
|
5,435
|
+2.9%
|
|
Total students
|
31,736
|
31,295
|
+1.4%
|
|
Medical and Veterinary
|
|||
|
September Semester(2)
|
|||
|
New students
|
872
|
889
|
-1.9%
|
|
Total students
|
5,608
|
5,887
|
-4.7%
|
|
1)
|
Includes the most recently reported enrollment sessions at Adtalem’s postsecondary institutions, excluding Brazil
|
|
2)
|
Includes enrollments in its medical and veterinary preparatory programs
|
|
September 30,
|
June 30,
|
September 30,
|
||||||||||
|
2019
|
2019
|
2018
|
||||||||||
|
(in thousands, except share and par value amounts)
|
||||||||||||
|
ASSETS:
|
||||||||||||
|
Current Assets:
|
||||||||||||
|
Cash and Cash Equivalents
|
$
|
121,079
|
$
|
204,202
|
$
|
334,222
|
||||||
|
Investments in Marketable Securities
|
8,763
|
8,680
|
8,402
|
|||||||||
|
Restricted Cash
|
710
|
1,022
|
877
|
|||||||||
|
Accounts Receivable, Net
|
116,212
|
83,560
|
108,213
|
|||||||||
|
Prepaid Expenses and Other Current Assets
|
39,476
|
29,313
|
60,031
|
|||||||||
|
Current Assets Held for Sale
|
169,873
|
177,923
|
227,641
|
|||||||||
|
Total Current Assets
|
456,113
|
504,700
|
739,386
|
|||||||||
|
Land, Building and Equipment:
|
||||||||||||
|
Land
|
41,441
|
41,938
|
41,183
|
|||||||||
|
Building
|
309,893
|
322,657
|
288,438
|
|||||||||
|
Equipment
|
235,027
|
228,533
|
221,294
|
|||||||||
|
Construction in Progress
|
8,681
|
13,545
|
25,799
|
|||||||||
|
595,042
|
606,673
|
576,714
|
||||||||||
|
Accumulated Depreciation
|
(314,219
|
)
|
(323,240
|
)
|
(306,340
|
)
|
||||||
|
Land, Building and Equipment Held for Sale, Net
|
73,763
|
81,250
|
81,029
|
|||||||||
|
Land, Building and Equipment, Net
|
354,586
|
364,683
|
351,403
|
|||||||||
|
Noncurrent Assets:
|
||||||||||||
|
Operating Lease Assets
|
195,238
|
—
|
—
|
|||||||||
|
Deferred Income Taxes
|
14,977
|
18,314
|
31,080
|
|||||||||
|
Intangible Assets, Net
|
295,324
|
297,989
|
240,166
|
|||||||||
|
Goodwill
|
686,992
|
687,256
|
627,239
|
|||||||||
|
Other Assets, Net
|
91,086
|
52,113
|
45,201
|
|||||||||
|
Other Assets Held for Sale
|
366,008
|
317,641
|
315,390
|
|||||||||
|
Total Noncurrent Assets
|
1,649,625
|
1,373,313
|
1,259,076
|
|||||||||
|
TOTAL ASSETS
|
$
|
2,460,324
|
$
|
2,242,696
|
$
|
2,349,865
|
||||||
|
LIABILITIES:
|
||||||||||||
|
Current Liabilities:
|
||||||||||||
|
Accounts Payable
|
$
|
44,674
|
$
|
53,385
|
$
|
48,087
|
||||||
|
Accrued Salaries, Wages and Benefits
|
30,071
|
46,664
|
32,056
|
|||||||||
|
Accrued Liabilities
|
61,966
|
76,529
|
80,591
|
|||||||||
|
Deferred Revenue
|
168,533
|
95,944
|
173,856
|
|||||||||
|
Current Operating Lease Liabilities
|
54,057
|
—
|
—
|
|||||||||
|
Current Portion of Long-Term Debt
|
3,000
|
3,000
|
3,000
|
|||||||||
|
Current Liabilities Held for Sale
|
50,174
|
36,109
|
121,496
|
|||||||||
|
Total Current Liabilities
|
412,475
|
311,631
|
459,086
|
|||||||||
|
Noncurrent Liabilities:
|
||||||||||||
|
Long-Term Debt
|
327,600
|
398,094
|
289,579
|
|||||||||
|
Long-Term Operating Lease Liabilities
|
192,055
|
—
|
—
|
|||||||||
|
Deferred Income Taxes
|
29,094
|
29,426
|
29,378
|
|||||||||
|
Other Liabilities
|
92,252
|
86,326
|
101,561
|
|||||||||
|
Noncurrent Liabilities Held for Sale
|
76,468
|
16,146
|
21,412
|
|||||||||
|
Total Noncurrent Liabilities
|
717,469
|
529,992
|
441,930
|
|||||||||
|
TOTAL LIABILITIES
|
1,129,944
|
841,623
|
901,016
|
|||||||||
|
NONCONTROLLING INTEREST
|
3,187
|
9,543
|
8,814
|
|||||||||
|
SHAREHOLDERS’ EQUITY:
|
||||||||||||
|
Common Stock, $0.01 Par Value, 200,000,000 Shares Authorized; 54,649,000, 55,303,000 and 59,120,000 Shares
Outstanding at September 30, 2019, June 30, 2019 and September 30, 2018, respectively
|
805
|
801
|
798
|
|||||||||
|
Additional Paid-in Capital
|
492,151
|
486,061
|
469,545
|
|||||||||
|
Retained Earnings
|
2,027,263
|
2,012,902
|
1,908,465
|
|||||||||
|
Accumulated Other Comprehensive Loss
|
(176,739
|
)
|
(137,290
|
)
|
(163,168
|
)
|
||||||
|
Treasury Stock, at Cost, 25,862,000, 24,830,000 and 20,727,000 Shares at September 30, 2019, June 30, 2019 and
September 30, 2018, respectively
|
(1,016,287
|
)
|
(970,944
|
)
|
(775,605
|
)
|
||||||
|
TOTAL SHAREHOLDERS’ EQUITY
|
1,327,193
|
1,391,530
|
1,440,035
|
|||||||||
|
TOTAL LIABILITIES, NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY
|
$
|
2,460,324
|
$
|
2,242,696
|
$
|
2,349,865
|
||||||
|
Three Months Ended
|
||||||||
|
September 30,
|
||||||||
|
2019
|
2018
|
|||||||
|
(in thousands, except per share amounts)
|
||||||||
|
REVENUE
|
$
|
254,613
|
$
|
236,939
|
||||
|
OPERATING COST AND EXPENSE:
|
||||||||
|
Cost of Educational Services
|
128,034
|
111,534
|
||||||
|
Student Services and Administrative Expense
|
99,087
|
89,164
|
||||||
|
Restructuring Expense
|
6,530
|
39,473
|
||||||
|
Gain on Sale of Assets
|
(4,779
|
)
|
—
|
|||||
|
Total Operating Cost and Expense
|
228,872
|
240,171
|
||||||
|
Operating Income (Loss) from Continuing Operations
|
25,741
|
(3,232
|
)
|
|||||
|
OTHER INCOME (EXPENSE):
|
||||||||
|
Interest and Dividend Income
|
678
|
969
|
||||||
|
Interest Expense
|
(5,328
|
)
|
(4,918
|
)
|
||||
|
Investment Gain
|
23
|
—
|
||||||
|
Net Other Expense
|
(4,627
|
)
|
(3,949
|
)
|
||||
|
Income (Loss) from Continuing Operations Before Income Taxes
|
21,114
|
(7,181
|
)
|
|||||
|
Income Tax (Provision) Benefit
|
(3,706
|
)
|
2,330
|
|||||
|
Income (Loss) from Continuing Operations
|
17,408
|
(4,851
|
)
|
|||||
|
DISCONTINUED OPERATIONS:
|
||||||||
|
Loss from Discontinued Operations Before Income Taxes
|
(2,883
|
)
|
(5,719
|
)
|
||||
|
Income Tax (Provision) Benefit
|
(273
|
)
|
985
|
|||||
|
Loss from Discontinued Operations
|
(3,156
|
)
|
(4,734
|
)
|
||||
|
NET INCOME (LOSS)
|
14,252
|
(9,585
|
)
|
|||||
|
Net Loss Attributable to Noncontrolling Interest from Continuing Operations
|
109
|
64
|
||||||
|
Net Income Attributable to Noncontrolling Interest from Discontinued Operations
|
—
|
(9
|
)
|
|||||
|
NET INCOME (LOSS) ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION
|
$
|
14,361
|
$
|
(9,530
|
)
|
|||
|
AMOUNTS ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION:
|
||||||||
|
Income (Loss) from Continuing Operations
|
$
|
17,517
|
$
|
(4,787
|
)
|
|||
|
Loss from Discontinued Operations
|
(3,156
|
)
|
(4,743
|
)
|
||||
|
NET INCOME (LOSS) ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION
|
$
|
14,361
|
$
|
(9,530
|
)
|
|||
|
EARNINGS (LOSS) PER COMMON SHARE ATTRIBUTABLE TO ADTALEM GLOBAL EDUCATION SHAREHOLDERS:
|
||||||||
|
Basic:
|
||||||||
|
Continuing Operations
|
$
|
0.32
|
$
|
(0.08
|
)
|
|||
|
Discontinued Operations
|
$
|
(0.06
|
)
|
$
|
(0.08
|
)
|
||
|
Total
|
$
|
0.26
|
$
|
(0.16
|
)
|
|||
|
Diluted:
|
||||||||
|
Continuing Operations
|
$
|
0.31
|
$
|
(0.08
|
)
|
|||
|
Discontinued Operations
|
$
|
(0.06
|
)
|
$
|
(0.08
|
)
|
||
|
Total
|
$
|
0.26
|
$
|
(0.16
|
)
|
|||
|
Three Months Ended
|
||||||||
|
September 30,
|
||||||||
|
2019
|
2018
|
|||||||
|
(in thousands)
|
||||||||
|
CASH FLOW FROM OPERATING ACTIVITIES:
|
||||||||
|
Net Income (Loss)
|
$
|
14,252
|
$
|
(9,585
|
)
|
|||
|
Loss from Discontinued Operations
|
3,156
|
4,734
|
||||||
|
Adjustments to Reconcile Net Income (Income) to Net Cash Provided by Operating Activities:
|
||||||||
|
Stock-Based Compensation Expense
|
5,223
|
4,137
|
||||||
|
Amortization and Adjustments to Operating Lease Assets
|
12,804
|
—
|
||||||
|
Depreciation
|
8,393
|
7,727
|
||||||
|
Amortization of Intangible Assets
|
2,534
|
1,605
|
||||||
|
Amortization of Deferred Debt Issuance Costs
|
392
|
392
|
||||||
|
Provision for Bad Debts
|
5,554
|
1,203
|
||||||
|
Deferred Income Taxes
|
2,991
|
7,915
|
||||||
|
Loss on Disposals, Accelerated Depreciation and Adjustments to Land, Building and Equipment
|
1,053
|
37,984
|
||||||
|
Realized Loss on Investments
|
11
|
—
|
||||||
|
Unrealized Loss on Investments
|
(33
|
)
|
—
|
|||||
|
Gain on Sale of Assets
|
(4,779
|
)
|
—
|
|||||
|
Changes in Assets and Liabilities:
|
||||||||
|
Accounts Receivable
|
(38,206
|
)
|
(39,199
|
)
|
||||
|
Prepaid Expenses and Other Current Assets
|
(13,646
|
)
|
(11,308
|
)
|
||||
|
Accounts Payable
|
(7,566
|
)
|
1,397
|
|||||
|
Accrued Salaries, Wages, Benefits and Liabilities
|
(19,010
|
)
|
(14,257
|
)
|
||||
|
Deferred Revenue
|
72,589
|
74,909
|
||||||
|
Operating Lease Liabilities
|
(13,681
|
)
|
—
|
|||||
|
Other Assets and Liabilities
|
1,270
|
(14,137
|
)
|
|||||
|
Net Cash Provided by Operating Activities-Continuing Operations
|
33,301
|
53,517
|
||||||
|
Net Cash Provided by Operating Activities-Discontinued Operations
|
14,167
|
24,497
|
||||||
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
47,468
|
78,014
|
||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Capital Expenditures
|
(10,436
|
)
|
(13,321
|
)
|
||||
|
Sales of Marketable Securities
|
290
|
—
|
||||||
|
Purchases of Marketable Securities
|
(292
|
)
|
(4,152
|
)
|
||||
|
Proceeds from Sale of Assets
|
6,421
|
—
|
||||||
|
Net Cash Used in Investing Activities-Continuing Operations
|
(4,017
|
)
|
(17,473
|
)
|
||||
|
Net Cash Used in Investing Activities-Discontinued Operations
|
(1,728
|
)
|
(2,946
|
)
|
||||
|
NET CASH USED IN INVESTING ACTIVITIES
|
(5,745
|
)
|
(20,419
|
)
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Proceeds from Exercise of Stock Options
|
828
|
10,492
|
||||||
|
Employee Taxes Paid on Withholding Shares
|
(5,045
|
)
|
(5,188
|
)
|
||||
|
Proceeds from Stock Issued Under Colleague Stock Purchase Plan
|
—
|
159
|
||||||
|
Repurchase of Common Stock for Treasury
|
(40,255
|
)
|
(59,175
|
)
|
||||
|
Borrowings Under Credit Facility
|
30,000
|
—
|
||||||
|
Repayments Under Credit Facility
|
(100,750
|
)
|
(750
|
)
|
||||
|
Proceeds from Down Payment on Seller Loan
|
5,200
|
—
|
||||||
|
Payment for Purchase of Noncontrolling Interest of Subsidiary
|
(6,247
|
)
|
—
|
|||||
|
Net Cash Used in Financing Activities-Continuing Operations
|
(116,269
|
)
|
(54,462
|
)
|
||||
|
Net Cash Used in Financing Activities-Discontinued Operations
|
(480
|
)
|
(470
|
)
|
||||
|
NET CASH USED IN FINANCING ACTIVITIES
|
(116,749
|
)
|
(54,932
|
)
|
||||
|
Effects of Exchange Rate Differences
|
(6,750
|
)
|
(1,579
|
)
|
||||
|
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
|
(81,776
|
)
|
1,084
|
|||||
|
Cash, Cash Equivalents and Restricted Cash at Beginning of Period
|
300,467
|
444,405
|
||||||
|
Cash, Cash Equivalents and Restricted Cash at End of Period
|
218,691
|
445,489
|
||||||
|
Less: Cash, Cash Equivalents and Restricted Cash of Discontinued Operations at End of Period
|
96,902
|
110,390
|
||||||
|
Cash, Cash Equivalents and Restricted Cash at End of Period
|
$
|
121,789
|
$
|
335,099
|
||||
|
Three Months Ended
|
||||||||||||
|
September 30,
|
||||||||||||
|
2019
|
2018
|
Increase
(Decrease) |
||||||||||
|
(in thousands)
|
||||||||||||
|
REVENUE:
|
||||||||||||
|
Medical and Healthcare
|
$
|
207,487
|
$
|
202,100
|
2.7
|
%
|
||||||
|
Financial Services
|
47,126
|
35,646
|
32.2
|
%
|
||||||||
|
Home Office and Other
|
—
|
(807
|
)
|
NM
|
||||||||
|
Total Consolidated Revenue
|
254,613
|
236,939
|
7.5
|
%
|
||||||||
|
OPERATING INCOME (LOSS):
|
||||||||||||
|
Medical and Healthcare
|
28,500
|
1,656
|
1,621.0
|
%
|
||||||||
|
Financial Services
|
2,128
|
4,750
|
(55.2
|
)%
|
||||||||
|
Home Office and Other
|
(4,887
|
)
|
(9,638
|
)
|
49.3
|
%
|
||||||
|
Total Consolidated Operating Income (Loss)
|
$
|
25,741
|
$
|
(3,232
|
)
|
NM
|
||||||
|
Three Months Ended
|
||||||||||||
|
September 30,
|
||||||||||||
|
2019
|
2018
|
Increase
(Decrease) |
||||||||||
|
(in thousands)
|
||||||||||||
|
Medical and Healthcare Operating Income
|
$
|
28,500
|
$
|
1,656
|
1,621.0
|
%
|
||||||
|
Restructuring Expense
|
127
|
39,015
|
(99.7
|
)%
|
||||||||
|
Medical and Healthcare Operating Income Excluding Special Items
|
$
|
28,627
|
$
|
40,671
|
(29.6
|
)%
|
||||||
|
Financial Services Operating Income
|
$
|
2,128
|
$
|
4,750
|
(55.2
|
)%
|
||||||
|
Restructuring Expense
|
1,979
|
—
|
NM
|
|||||||||
|
Financial Services Operating Income Excluding Special Items
|
$
|
4,107
|
$
|
4,750
|
(13.5
|
)%
|
||||||
|
Home Office and Other Operating Loss
|
$
|
(4,887
|
)
|
$
|
(9,638
|
)
|
49.3
|
%
|
||||
|
Restructuring Expense
|
4,424
|
458
|
865.9
|
%
|
||||||||
|
Gain on Sale of Assets
|
(4,779
|
)
|
—
|
NM
|
||||||||
|
Home Office and Other Operating Loss Excluding Special Items
|
$
|
(5,242
|
)
|
$
|
(9,180
|
)
|
42.9
|
%
|
||||
|
Adtalem Global Education Operating Income (Loss)
|
$
|
25,741
|
$
|
(3,232
|
)
|
NM
|
||||||
|
Restructuring Expense
|
6,530
|
39,473
|
(83.5
|
)%
|
||||||||
|
Gain on Sale of Assets
|
(4,779
|
)
|
—
|
NM
|
||||||||
|
Adtalem Global Education Operating Income Excluding Special Items
|
$
|
27,492
|
$
|
36,241
|
(24.1
|
)%
|
||||||
|
Three Months Ended
|
||||||||
|
September 30,
|
||||||||
|
2019
|
2018
|
|||||||
|
(in thousands, except per share amounts)
|
||||||||
|
Net Income (Loss)
|
$
|
14,361
|
$
|
(9,530
|
)
|
|||
|
Earnings (Loss) per Share (diluted-2019, basic-2018)
|
$
|
0.26
|
$
|
(0.16
|
)
|
|||
|
Continuing Operations:
|
||||||||
|
Restructuring Expense
|
$
|
6,530
|
$
|
39,473
|
||||
|
Effect on Earnings per Share (diluted)
|
$
|
0.12
|
$
|
0.64
|
||||
|
Gain on Sale of Assets
|
$
|
(4,779
|
)
|
$
|
—
|
|||
|
Effect on Earnings per Share (diluted)
|
$
|
(0.09
|
)
|
$
|
—
|
|||
|
Income Tax Impact on Non-GAAP Adjustments
|
$
|
(343
|
)
|
$
|
(7,952
|
)
|
||
|
Effect on Earnings per Share (diluted)
|
$
|
(0.01
|
)
|
$
|
(0.13
|
)
|
||
|
Discontinued Operations, net of tax
|
$
|
3,156
|
$
|
4,743
|
||||
|
Effect on Earnings per Share (diluted)
|
$
|
0.06
|
$
|
0.08
|
||||
|
Net Income from Continuing Operations Excluding Special Items, net of tax
|
$
|
18,925
|
$
|
26,734
|
||||
|
Earnings per Share from Continuing Operations Excluding Special Items, net of tax (diluted)
|
$
|
0.34
|
$
|
0.44
|
||||
|
Shares used in Basic EPS Calculation
|
N/A
|
60,328
|
||||||
|
Shares used in Diluted EPS Calculation
|
56,140
|
61,202
|
||||||